PODCAST
Trial Site News Podcast: Hybrid Clinical Trials During and Post-COVID-19
Ed Seguine, chief executive officer of Clinical Ink, talks about how hybrid trials, bring your own device (BYOD) ePRO, and direct data capture (DDC) can provide a valuable solution during and following a healthcare crisis like COVID-19.
Clinical Ink is the leader in virtual and hybrid virtual trials. Implementing a virtual eSource platform wherever possible can ease operations and facilitate rapid, safety-conscious, cost-effective research. BYOD is an important tool for communicating with patients, capturing and sharing their inputs efficiently, and maintaining patient engagement for better adherence and retention throughout your trial.